In vitro activity of delafloxacin against clinical isolates of carbapenem-resistant Pseudomonas aeruginosa in a stage prior to the clinical use of this drug
Revista Española de Quimioterapia · 26.01.2024 · 37 (1) · 104-105
DOI: 10.37201/req/080.2023 ↗Kurz gefasst
Leserbrief in der Zeitschrift Revista Española de Quimioterapia, online erschienen am 22.12.2023. Verfasst von C García-Rivera und 6 weiteren Autor:innen. Beteiligte Einrichtung: María-Paz Ventero, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Av. Pintor Baeza 12, 03010. Alicante, Spain. Maripazvm@gma…. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Pseudomonas Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- María-Paz Ventero, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Av. Pintor Baeza 12, 03010. Alicante, Spain. Maripazvm@gmail.com.
Zitieren
APA
García-Rivera, C., Navarro, M., Parra, M., Sánchez Bautista, A., Gómez, I., Ventero, M. P., & Rodríguez, J. C. (2024). In vitro activity of delafloxacin against clinical isolates of carbapenem-resistant Pseudomonas aeruginosa in a stage prior to the clinical use of this drug. Revista Española de Quimioterapia, 37(1), 104-105. https://doi.org/10.37201/req/080.2023
Vancouver
García-Rivera C, Navarro M, Parra M, Sánchez Bautista A, Gómez I, Ventero MP, et al. In vitro activity of delafloxacin against clinical isolates of carbapenem-resistant Pseudomonas aeruginosa in a stage prior to the clinical use of this drug. Revista Española de Quimioterapia. 2024;37(1):104-105. doi:10.37201/req/080.2023
BibTeX
@article{GarcaRivera2024,
author = {García-Rivera, C and Navarro, M and Parra, M and Sánchez Bautista, A and Gómez, I and Ventero, M P and Rodríguez, J C},
title = {In vitro activity of delafloxacin against clinical isolates of carbapenem-resistant Pseudomonas aeruginosa in a stage prior to the clinical use of this drug},
journal = {Revista Española de Quimioterapia},
year = {2024},
volume = {37},
number = {1},
pages = {104--105},
doi = {10.37201/req/080.2023}
}
EUVIMED